Elevated hematocrit is the most common side effect of testosterone replacement therapy, affecting roughly a third to two-thirds of men on injectable testosterone depending on the formulation. Hematocrit above 51% typically triggers a dose adjustment, and levels above 54% are the threshold where most guidelines recommend stopping testosterone altogether. The good news: several practical strategies can bring your levels down without necessarily ending treatment.
Why TRT Raises Hematocrit
Testosterone is a potent stimulator of red blood cell production through two main pathways. First, it increases erythropoietin (EPO), the hormone your kidneys release to signal your bone marrow to make more red blood cells. Studies show testosterone can boost EPO levels by about 34%. Second, testosterone suppresses hepcidin, a liver protein that normally limits how much iron is available for building new red blood cells. With hepcidin suppressed, more iron flows to your bone marrow, and production ramps up.
The result is more red blood cells packed into the same volume of blood, which is exactly what hematocrit measures. A higher hematocrit means thicker blood, and that’s where the risk begins.
Why It Matters: The Cardiovascular Risk
Men who develop secondary polycythemia (high red blood cell counts caused by TRT) have a meaningfully higher risk of cardiovascular events. A large study published in The Journal of Urology found that men with polycythemia on testosterone therapy had a 35% higher odds of major adverse cardiovascular events or blood clots compared to men with normal hematocrit on the same therapy (5.15% vs. 3.87% event rate). The risk was particularly elevated for heart attacks (81% higher odds) and venous blood clots (51% higher odds).
This elevated risk appears concentrated in the first year of therapy and is more pronounced in men under 65. Interestingly, stroke and mortality risk did not differ significantly between groups. The cardiovascular concern becomes statistically clear once hematocrit crosses 54%, which is why that number serves as the hard stop in clinical guidelines.
Adjust Your Dose
The most straightforward intervention is reducing your testosterone dose. U.S. Department of Veterans Affairs guidelines recommend dose adjustments when hematocrit exceeds 51%, and stopping testosterone entirely if it exceeds 54%. A lower dose means less EPO stimulation and less hepcidin suppression, which slows red blood cell production. Many men find that a modest dose reduction of 10-20% is enough to pull hematocrit back into a safe range while still maintaining adequate testosterone levels.
Work with your prescribing provider to find the lowest effective dose. If your total testosterone is running well above 900 ng/dL, there’s likely room to cut back without losing the benefits you’re after.
Switch Your Injection Route
How you take testosterone matters as much as how much you take. Intramuscular injections create sharp peaks in blood testosterone levels, and as many as 40-66% of men on intramuscular testosterone develop hematocrit levels at or above 53%. Subcutaneous injections produce more gradual absorption with lower peaks. In a cohort of 94 men using subcutaneous testosterone cypionate, only 32% developed erythrocytosis, a notable reduction compared to intramuscular rates.
If you’re currently injecting intramuscularly and struggling with hematocrit, ask your provider about switching to subcutaneous injections with a smaller needle (typically insulin syringes) into abdominal or thigh fat.
Rethink Injection Frequency
This one may surprise you: more frequent injections can actually make hematocrit worse, not better. A study comparing men injecting once weekly versus twice weekly found that the twice-weekly group had a higher maximum hematocrit (51.4% vs. 49.2%) and nearly three times the rate of erythrocytosis (29% vs. 11%). The researchers concluded that dosing frequency, rather than total weekly dose, is an important factor in red blood cell overproduction.
This runs counter to the common advice in TRT communities that splitting doses into smaller, more frequent injections is always better. While more frequent dosing does smooth out testosterone peaks and troughs, the cumulative stimulation of red blood cell production may be greater. If your hematocrit is creeping up on a frequent dosing schedule, consolidating to fewer injections per week is worth discussing with your provider.
Therapeutic Phlebotomy
Blood donation or therapeutic phlebotomy is the fastest way to drop hematocrit. Removing roughly one pint (about 500 mL) of blood will typically lower hematocrit by 2-3 percentage points within a day or two. Many men on TRT donate blood every 8-12 weeks to keep levels in check.
Regular blood donation through the Red Cross or a community blood bank is the simplest route if you’re eligible. If your hematocrit is already above the donation threshold (most blood banks cap donors at 55-56%), you’ll need a prescription for therapeutic phlebotomy, which your provider can order at a hospital or infusion center. The downside of relying solely on phlebotomy is that repeated sessions deplete your iron stores over time, which can cause fatigue and other symptoms of iron deficiency even while your red blood cell count stays high.
Stay Hydrated
Hematocrit is a ratio of red blood cells to total blood volume, so dehydration artificially inflates it. If you’re mildly dehydrated when your blood is drawn, your hematocrit will read higher than it actually is under normal conditions. This isn’t a fix for genuinely elevated red blood cell production, but consistent hydration (targeting at least 2-3 liters of water daily, more if you exercise heavily or live in a hot climate) ensures your readings reflect reality and may keep you a point or two lower on labs.
Dietary Approaches
A small but intriguing study from the late 1980s found that eating half a grapefruit per day significantly lowered elevated hematocrit in human subjects. Eating a full grapefruit didn’t lower it further, suggesting even a modest amount was enough. The compound likely responsible is naringin, a flavonoid concentrated in grapefruit. However, grapefruit interacts with a long list of medications by inhibiting liver enzymes that metabolize drugs, so check whether it’s safe with anything else you take before adding it to your routine.
Beyond grapefruit, no specific food has strong clinical evidence for lowering hematocrit. Avoiding excess iron supplementation and iron-rich foods (like organ meats or heavily fortified cereals) makes sense, since testosterone is already unlocking more of your stored iron for red blood cell production.
Medications That Lower Hematocrit
Certain blood pressure medications in the ARB class (angiotensin receptor blockers) have a well-documented side effect of lowering red blood cell counts. These drugs work in part by blocking the red-blood-cell-stimulating effects of angiotensin II and by improving kidney blood flow, which reduces the oxygen-deficit signal that drives EPO production. Reductions in hemoglobin greater than 1 g/dL have been reported, with effects appearing as early as three weeks and reaching their lowest point around three months.
If you happen to have high blood pressure or other indications for an ARB, this dual benefit is worth discussing with your provider. These medications aren’t typically prescribed solely to manage TRT-related hematocrit, but for men who need blood pressure management anyway, they can address two problems at once.
Consider Topical Testosterone
Testosterone gels and creams deliver a lower, steadier stream of testosterone compared to injections, which generally produces less dramatic hematocrit elevation. The tradeoff is that topical formulations can be less reliable in absorption, require daily application, and carry the risk of transferring testosterone to partners or children through skin contact. For men who consistently struggle with hematocrit on injectables despite dose and frequency adjustments, switching to a topical may be the change that keeps levels manageable.
Monitoring Schedule
Once you start TRT, hematocrit should be checked at baseline, then at 3-6 months, and at least annually after that. If your levels have been borderline or required intervention, more frequent monitoring (every 2-3 months) is reasonable until your values stabilize. Always get your blood drawn under consistent conditions: same time of day, same hydration habits, ideally at trough (right before your next injection) for the most comparable results over time.